Two Steps Forward, One Step Back: 50 Years of Societal Value From LDL-C–Lowering Therapies
April 13th 2021Low-density lipoprotein cholesterol (LDL-C)–lowering therapies have yielded significant value to society through reduced costs for both fatal and nonfatal cardiovascular disease events. The vast majority of this value has accrued to patients.
Read More
2 Clarke Drive
Cranbury, NJ 08512